Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06354777 · ClinicalTrials.gov registry record
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
A clinical trial of Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.
- Active
- Registry status
- 312
- Enrollment target
- 6
- Study locations
NCT06354777: Active study of Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.
NCT06354777 is a study of Atrial Fibrillation that is active but no longer recruiting, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 312 participants, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (90% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06354777, a study of Atrial Fibrillation, is active but no longer recruiting, sponsored by Heart Rhythm Clinical and Research Solutions.
- ACTIVE NOT RECRUITING
- Registry status
- 312 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multi-center sub-study examining the effectiveness of active esophageal cooling on subjects undergoing left atrial ablation for symptomatic Paroxysmal Atrial Fibrillation or Persistent Atrial Fibrillation.
Primary Outcome
Freedom from atrial arrhythmia recurrence at 90 days post procedure.
Conditions Studied
Interventions
- DEVICE Atrial Ablation
Study Locations (6)
Arizona
- Valley Heart Rhythm Specialists - Chandler
Indiana
- Ascension St. Vincent Hospital Indianapolis - Indianapolis
Michigan
- Corewell Health Research Institute - Royal Oak
Ohio
- Christ Hospital - Cincinnati
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Washington
- MultiCare Institute for Research & Innovation - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2024-04-03 |
| Est. Completion | 2026-12-30 |
What the registry record for NCT06354777 still lists
NCT06354777 is an observational study that tracks outcomes without assigning an intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Atrial Ablation is the first listed.
NCT06354777 lists 6 locations in 6 states (Arizona, Indiana, Michigan).
Frequently Asked Questions
What is clinical trial NCT06354777 about?
NCT06354777 is a clinical study titled "REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry". This is a multi-center sub-study examining the effectiveness of active esophageal cooling on subjects undergoing left atrial ablation for symptomatic Paroxysmal Atrial Fibrillation or Persistent Atrial Fibrillation.
What is the current status of trial NCT06354777?
This trial is currently active not recruiting. The enrollment target is 312 participants. The study started on 2024-04-03. Estimated completion is 2026-12-30.
What conditions does trial NCT06354777 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT06354777?
The interventions under investigation include: Atrial Ablation (DEVICE).
Who is sponsoring clinical trial NCT06354777?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06354777 being conducted?
This trial has 6 study locations across Arizona, Indiana, Michigan, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06354777's enrollment target sits among peer trials
312 80th of 202 higher than 123 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI